NCT04749394 2022-08-16
A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy
ChineseAMS
Phase 2 Unknown
Clinical Trials
5 trialsNCT04861467 2021-04-27
Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
ChineseAMS
Phase 2 Unknown
NCT04683198 2020-12-24
Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC
ChineseAMS
Phase 2 Unknown
NCT04447274 2020-06-25
A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS
ChineseAMS
Phase 2 Unknown
NCT03603756 2020-02-11
SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer
ChineseAMS
Phase 2 Unknown